Previous Investigations
Other Litigations
|
Patients With Drug-Eluting Stents at Increased Risk for Blood Clots
says Cleveland Clinic Foundation Heart Center
A report, published on November 29th in the American Journal of
Medicine, states that there is as much as a four- to five-fold increased
risk for late thrombosis--blood clots formation--in patients with drug-coated
stents, compared to the older bare-metal version.
The Cleveland Clinic
study--a meta-analysis--included 14 studies with a total of 6,675 patients.
A growing body of evidence indicates that the drug-eluting stents
(including Taxus and Cypher), compared to the bare-metal versions, increase the
risk of blood clot formation long after they are implanted. This, in turn, could
lead to heart attacks in patients.
Weitz & Luxenberg is no longer accepting Taxus Stent cases.
see also:
FREE Legal Review
TAXUS Stent Attorneys - Help filing a TAXUS lawsuit for TAXUS stent during your angioplastyTAXUS Stent Attorneys - The TAXUS Stent was used to clear and prop open clogged arteries
Research Center
FREE TAXUS Stent Lawsuit InformationFor FREE TAXUS Stent lawsuit info, you need the right law firm for you
Taxus Stent
Taxus Stent Lawyer InformationLawyer provides informational update on taxus stent health risk.
